Inner Mongolia Jinyu Group Co., Ltd. (600201)

Inner Mongolia Jinyu Group Co., Ltd. (600201)

Inner Mongolia Jinyu Group Co., Ltd. is a diversified industrial group with biopharmaceutical and real estate development as the leading industries. The main member enterprises include: Jinyu Baoling biopharmaceutical Co., Ltd., Yangzhou Youbang biopharmaceutical Co., Ltd., Inner Mongolia Jinyu land Co., Ltd., Inner Mongolia Shandan Cashmere Products Co., Ltd. With 1335 employees, the company is an advanced enterprise in Inner Mongolia Autonomous Region and an AAA credit enterprise in Hohhot.

In March 1993, Inner Mongolia Jinyu Group Co., Ltd. was established by directional raising, with a total share capital of 45.2025 million shares. In 1995, the company increased capital and shares according to the development needs, and the total share capital of the company increased to 62.025 million shares. In January 1999, the company was successfully listed on the Shanghai Stock Exchange, with a total share capital of 97.025 million shares, of which 35 million were listed and circulated. The stock is referred to as "Jinyu group" for short, and the stock code is "600201". In December 2000, the company implemented share allotment, and the share capital increased to 109.21325 million shares. In June 2004, the company implemented the conversion scheme of 10 to 10, and the total share capital increased to 218426500 shares. In July 2006, the company successfully completed the reform of non tradable shares, which means that the company has gradually entered the era of full circulation of share capital.

As of September 30, 2007, the total share capital of the company is 280.81493 million shares, the total market value has exceeded 4 billion yuan, the total assets is 1.347 billion yuan, the main business income is 329 million yuan, and the operating performance has maintained a stable growth trend.

Since its listing in 1998, the company has experienced a full ten years. According to the strategic goal of "becoming a national famous brand of biopharmaceuticals and the first brand of real estate development in the whole region", the company has made full use of the financing advantages of listed companies by means of industrial restructuring and asset restructuring, continuously increased investment in biopharmaceuticals and real estate development, and concentrated resources in advantageous industries, To achieve the strategic goal of making advantageous industries bigger and stronger.

>> tungsten carbide rings black